Bill Ackman's Defense Of Valeant Pharmaceuticals Takes Long View On Drugmaker's Woes |
| October 31, 2015 | October 2015 Bond Updates |
|
Unsurprisingly, Pershing Square's Bill Ackman wasn't able to convince Wall Street once and for all whether embattled drugmaker Valeant Pharmaceuticals can recover from its woes or will continue heading south. |
| View more at: http://www.forbes.com/sites/antoinegara/2015/10/30/bill-ackmans-defense-of-valeant-pharmaceuticals-takes-long-view-on-drugmakers-woes/ |
| Related News |
|